Quintiles’ names new CEO; Gillings stays on as executive chairman

Quintiles CEO Dennis Gillings is stepping away from the top post of the company he founded and built into the largest clinical research organization in the industry.Tom Pike, a 22-year veteran of management consultant company Accenture, has been appointed Quintiles’ new CEO. Pike will join the Durham, North Carolina-based CRO on April 30. Gillings will [...]

[Read more of this report]


Pharmaceutical company taps Novartis and Pfizer for management team

A pharmaceutical company has tapped Novartis (NYSE:NVS) and Pfizer (NYSE:PFE) for chief medical officer and general counsel positions.Dr. Clarence L. Young will serve as chief medical officer and will lead Iroko Pharmaceuticals’ clinical programs for the company’s investigational, nonsteroidal anti-inflammatory drugs.He previously worked at Novartis as global head of targeted therapies and integrated hospital care [...]

[Read more of this report]


Amicus Therapeutics names new CFO

Amicus Therapeutics (NASDAQ:FOLD) has hired a biopharmaceutical industry veteran as chief financial officer of its business to develop treatments for lysosomal storage diseases and neurodegenerative diseases.William D. Baird III previously worked at PTC Therapeutics where he served for 10 years, seven as CFO, according to a company statement.Amicus’ lead drug undergoing phase 3 clinical trials [...]

[Read more of this report]


Pharma’s shifting strategy means more jobs for computational biologists

An article discussing the burgeoning field of Computational Biology was just published on the Science Careers website.For the biopharmaceutical industry, big data is the abundant and ever-growing compendium of disease associations and genomic data that is (in many cases) publicly available. Instead of following the traditional pharma paradigm of systematically testing the effects of known [...]

[Read more of this report]


Sales jobs galore at Medtronic Cardiac Connected Care and Neuromodulation

With all the talk of medical device jobs shifting overseas because of the headwinds the industry is facing, it’s as if the device domain is doomed here.And yet bright spots remain within the device sector. For Medtronic (NYSE:MDT), it’s in the Cardiac Connected Care Division as well as in Neuromodulation.There are 50 open Medtronic sales [...]

[Read more of this report]


Quest Diagnostics announces new CEO, gets approval for C difficile test

Quest Diagnostics (NYSE:DGX), one of the largest diagnostic testing providers, has announced a replacement for its outgoing CEO.Dr. Surya N. Mohapatra will be succeeded by Philips Healthcare CEO Steve Rusckowski effective May 1, according to a company statement.Rusckowski held management positions with the Healthcare Division of Hewlett-Packard/Agilent Technologies and was the general manager of Agilent’s [...]

[Read more of this report]


Jobs Advice: How do laid off pharma reps land a job in medical device sales?

2011 was a bad year for the pharmaceutical industry with layoff announcements coming from Novartis, Abbott Laboratories, AstraZeneca and many more. As a result, there are many more jobless pharma reps than there are jobs.Here are some tips that can help laid off pharma reps make the switch into medical device sales:Forget headhunters and recruitersIn [...]

[Read more of this report]


Former head of Sanofi vaccines division becomes infectious disease biotech CEO

The former head of Sanofi’s (NYSE:SNY) vaccines division, one of the largest vaccine companies in the world, has joined a biotechnology company developing infectious disease vaccines as its CEO.Wayne Pisano will lead Cranbury, New Jersey-based VaxInnate, a biotechnology company founded by two Yale School of Medicine immunobiology professors in 2002 — Ruslan Medzhitov and Richard [...]

[Read more of this report]


Senate passes JOBS bill, but will early stage biotech companies benefit?

The U.S. Senate has approved a bill that will make it easier for early stage companies to raise money by broadening the number of people that can invest in them and help companies file for initial public offerings.But will it mean more biotechnology startups will have the money to survive the multiyear journey to bring [...]

[Read more of this report]


Patent box? Ticked. GSK’s $800M plans show Europe’s tax edge over U.S.

GlaxoSmithKline (NYSE:GSK) is investing nearly $800 million to build a new manufacturing plant in the United Kingdom, part of a capital investment effort that could create 1,000 new jobs.The new plant, in a region north of London, will be the company’s first new U.K. factory in nearly 40 years, GSK said in today’s announcement. But [...]

[Read more of this report]


« Newer PostsOlder Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics